Brief: Pardes Biosciences Enters Into Agreement To Be Acquired By Medipacific For Between $2.02 & $2.19 In Cash Per Share Plus Contingent Value Rights
17/07/2023 12:11
July 17 (Reuters) - Pardes Biosciences Inc PRDS.O :
* PARDES BIOSCIENCES INC - PARDES WILL MERGE WITH A
SUBSIDIARY OF
PURCHASER
* PARDES BIOSCIENCES ENTERS INTO AGREEMENT TO BE ACQUIRED BY
MEDIPACIFIC, INC. FOR BETWEEN $2.02 AND $2.19 IN CASH PER SHARE
PLUS CONTINGENT VALUE RIGHTS
* PARDES BIOSCIENCES INC - ACQUISITION IS EXPECTED TO CLOSE
IN Q3
OF 2023
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pardes Biosciences
See all newsBrief: Pardes Biosciences Inc - Total Cash Amount That Medipacific Sub, Inc. Will Pay Pursuant To Terms Of Offer And Merger Agreement Is $2.13 Per Share
U.S. STOCKS ON THE MOVE-Argenx, ViewRay, Ford
Pardes Biosciences up on buyout deal with MediPacific
U.S. STOCKS ON THE MOVE-Activision Blizzard, Tesla, Paramount Global
Pardes Biosciences gains on buyout deal with MediPacific